More
    HomeEcosystem NewsLatest FundingSouth African Health-Tech Startup RecoMed Secures Major Funding from Japanese Pharma Giant

    South African Health-Tech Startup RecoMed Secures Major Funding from Japanese Pharma Giant

    Published on

    spot_img

    South African digital healthcare marketplace startup RecoMed has struck a significant deal with Japanese pharmaceutical firm Eisai, securing a substantial yet undisclosed amount of funding. The investment aims to fuel RecoMed’s expansion plans and further develop its innovative platform, which connects healthcare practitioners and patients seamlessly.

    RecoMed operates as a tech-driven online healthcare marketplace and booking platform, offering patients the convenience of booking appointments with various healthcare providers through their phones, tablets, or PCs. The platform has gained traction, facilitating over 250,000 unique patient visits monthly and confirming over 100,000 bookings every month.

    The startup, which boasts a user base of over 3,000 healthcare providers, witnessed remarkable growth in recent years. RecoMed’s revenue surged by 150 per cent in 2023, setting the stage for further expansion with the backing of Eisai’s investment. Although the exact amount remains undisclosed, it marks RecoMed’s largest funding round yet, surpassing the US$1.45 million raised from the Vunani Fintech Fund in 2021.

    The infusion of capital from Eisai will enable RecoMed to pioneer digital healthcare solutions for breast cancer, a critical initiative amidst rising breast cancer rates exacerbated by COVID-19 screening delays. Sheraan Amod, founder and CEO of RecoMed, expressed enthusiasm about the partnership, highlighting Eisai’s clear vision and alignment with RecoMed’s mission to enhance healthcare accessibility through digital platforms.

    According to Amod, the investment will primarily focus on enhancing RecoMed’s technology, raising platform awareness, and creating a more robust digital healthcare journey for patients. With an initial emphasis on breast cancer, RecoMed aims to improve patient treatment journeys and overall outcomes across various diseases.

    Shin Ujiie, vice president for corporate strategy at Eisai, emphasized the significance of utilizing digital platforms to streamline the patient journey. He praised RecoMed’s innovative approach to digital health services and expressed confidence in the partnership’s potential to enhance healthcare accessibility.

    As healthcare complexities persist, partnerships like RecoMed and Eisai’s underscore the importance of leveraging technology to address critical healthcare challenges. With this latest funding boost, RecoMed is poised to make significant strides in revolutionizing the healthcare landscape, starting with its pioneering efforts in breast cancer care.

    Charles Rapulu Udoh is a Lagos-based lawyer, who has several years of experience working in Africa’s burgeoning tech startup industry. He has closed multi-million dollar deals bordering on venture capital, private equity, intellectual property (trademark, patent or design, etc.), mergers and acquisitions, in countries such as in the Delaware, New York, UK, Singapore, British Virgin Islands, South Africa, Nigeria etc. He’s also a corporate governance and cross-border data privacy and tax expert. As an award-winning writer and researcher, he is passionate about telling the African startup story, and is one of the continent’s pioneers in this regard.

    Latest articles

    Orange Corners Deepens North African Push with New Startup Fund in Tunisia

    The fund operates a two-track model, offering everything from prototype vouchers and monthly allowances for idea-stage founders to more substantial seed funding.

    Ghana’s Digital Lenders Face a Costly Upgrade: $162K License Fees and No More Public Shaming

    Lenders are explicitly forbidden from compounding interest on short-term loans.

    Months After Raising $4.2M, Kenyan Healthtech Ilara Health Announces Major Cuts

    “This is a difficult moment for our team, especially in light of recent strides we have made in the business."

    Algebra Ventures Brings on New Investor in Rare Egyptian LP Secondary Deal

    Algebra Ventures has backed some of Egypt’s most well-known startups and invests from seed to Series B stages.

    More like this

    Orange Corners Deepens North African Push with New Startup Fund in Tunisia

    The fund operates a two-track model, offering everything from prototype vouchers and monthly allowances for idea-stage founders to more substantial seed funding.

    Ghana’s Digital Lenders Face a Costly Upgrade: $162K License Fees and No More Public Shaming

    Lenders are explicitly forbidden from compounding interest on short-term loans.

    Months After Raising $4.2M, Kenyan Healthtech Ilara Health Announces Major Cuts

    “This is a difficult moment for our team, especially in light of recent strides we have made in the business."